Showing 1 - 4 results of 4 for search 'Michele A. Kohli', query time: 0.03s Refine Results
  1. 1
    The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany

    The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany by Michele A. Kohli, Michael Maschio, Shannon Cartier, Joaquin Mould-Quevedo, Frank-Ulrich Fricke

    Published 2022-08-01
    Get full text
    Article
  2. 2
    The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom

    The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom by Michele A. Kohli, Michael Maschio, Joaquin F. Mould-Quevedo, Michael Drummond, Milton C. Weinstein

    Published 2021-11-01
    Get full text
    Article
  3. 3
    The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom

    The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom by Michele A. Kohli, Michael Maschio, Joaquin F. Mould-Quevedo, Mansoor Ashraf, Michael F. Drummond, Milton C. Weinstein

    Published 2021-06-01
    Get full text
    Article
  4. 4
    An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom

    An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom by Michael Maschio, Michele A. Kohli, Mansoor Ashraf, Michael F. Drummond, Milton C. Weinstein, Joaquin F. Mould-Quevedo

    Published 2022-04-01
    Get full text
    Article

Search Tools: